Back to search

University of Washington

Genetically Engineered Human Stem Cell-Derived Cardiomyocytes to Study the Novel Titin Isoform Cronos in Development and Disease

Abstract

dc:description.abstract

The giant sarcomere protein titin plays a number of important roles in the cardiomyocyte, and truncating mutations to the gene that encodes this protein (TTN) are the leading known cause of dilated cardiomyopathy. Despite the frequency with which these mutations occur, significant questions remain about how they act to cause disease. Of particular interest is the clustering of truncating mutations to the A-band of TTN in DCM cohorts. To investigate this phenomenon, we genetically engineered human induced pluripotent stem cell (hiPSC) lines carrying homozygous mutations in the Z-disk (TTN-Z-/-) and A-band (TTN-A-/-) region of the gene. Surprisingly, TTN-Z-/- cardiomyocytes (CMs) visibly contracted and were found to express a C-terminal portion of titin, which we determined to be the isoform Cronos titin. TTN-A-/- CMs produce truncation products of both full-length and Cronos titin and are not able to produce sarcomeres. Using a custom antibody, we demonstrate that TTN-Z-/- CMs only express Cronos titin and are able to form sarcomeres with this isoform in the absence of full-length titin. However, these cells produce drastically reduced contractile force as both single cells and in engineered heart tissues (EHTs). Using live cell imaging, we determine this is due to an inability of TTN-Z-/- CMs to properly bundle myofibrils, resulting in sarcomeric instability. We further investigate the biological relevance of Cronos titin by investigating its expression in human cardiac tissue. Genomic methylation, transcript levels, and immunostaining indicate that Cronos titin is most highly expressed in fetal cardiac tissue and is present at lower but detectable levels in adult left ventricular tissue. This indicates that Cronos titin is predominantly a developmental isoform. Finally, we investigate the role of Cronos titin by generating two Cronos knock-out (KO) hiPSC lines. When differentiated into cardiomyocytes, these cells do not express Cronos but do express full-length titin at comparable levels to wildtype controls. EHTs generated with Cronos KO CMs produce drastically lower force than control cells and exhibit significant myofibrillar disarray, indicating that Cronos titin is necessary for proper cardiomyocyte function. As a whole, this work demonstrates for the first time that Cronos titin is expressed in human cardiomyocytes, is necessary for proper sarcomere function, and is an important isoform of titin that may play a role in dilated cardiomyopathy.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zaunbrecher, Rebecca
Advisors dc:contributor.advisor
  • Regnier, Michael
  • Murry, Charles E

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • none
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1773/43293

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Zaunbrecher, Rebecca. Genetically Engineered Human Stem Cell-Derived Cardiomyocytes to Study the Novel Titin Isoform Cronos in Development and Disease. 2019. http://hdl.handle.net/1773/43293